Module 10 part 1- Drugs Impacting the Gastrointestinal System

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/22

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 5:36 PM on 7/29/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

23 Terms

1
New cards

Classes of Antiulcer Drugs

There are 5 major classes of antiulcer drugs:

  • Antibiotics – Eradicate Helicobacter pylori (H. pylori), a common cause of peptic ulcers.

  • Antisecretory agents – Reduce gastric acid secretion (primarily Proton Pump Inhibitors [PPIs]).

  • Mucosal protectants – Form a protective barrier over the ulcer to shield it from stomach acid (e.g., sucralfate and bismuth subsalicylate).

  • Antisecretory agents that enhance mucosal defenses – Reduce acid while strengthening the stomach's protective lining (e.g., misoprostol, a prostaglandin analog).

  • Antacids – Weak bases that neutralize existing stomach acid (e.g., Tums and Maalox).

2
New cards

Standard Treatment for H. pylori Peptic Ulcers (Bismuth Quadruple Therapy)

Bismuth quadruple therapy is the current standard treatment for peptic ulcers caused by H. pylori.

It consists of:

  • 2 antibiotics:

    • Metronidazole

    • Tetracycline

  • 1 Proton Pump Inhibitor (PPI)

  • Bismuth subsalicylate

Remember:
2 antibiotics + PPI + Bismuth = Bismuth Quadruple Therapy

3
New cards

Triple Therapy vs. Bismuth Quadruple Therapy

  • Old standard: Triple therapy with clarithromycin.

  • Current standard: Bismuth quadruple therapy.

  • Reason for the change: Higher rates of clarithromycin resistance have developed, making triple therapy less effective.

4
New cards

Antisecretory Agents vs. Antisecretory Agents that Enhance Mucosal Defenses

Antisecretory agents

  • Primarily refers to Proton Pump Inhibitors (PPIs).

  • Main action: Decrease gastric acid secretion.

Antisecretory agents that enhance mucosal defenses

  • Misoprostol is the main drug.

  • It is a prostaglandin analog.

  • Actions:

    • Decreases gastric acid secretion.

    • Enhances the stomach's natural protective (mucosal) defenses.

5
New cards

Mucosal Protectants

Pure mucosal protectants work by creating a protective barrier between stomach acid and the gastric mucosa/ulcer.

Examples:

  • Sucralfate

  • Bismuth subsalicylate

Key concept: They protect the ulcer rather than significantly reducing acid production.

6
New cards

Antacids

  • Antacids are weak bases.

  • They provide mild neutralization of stomach acid.

  • They work by neutralizing acid that is already present in the stomach rather than preventing acid production.

Examples:

  • Tums

  • Maalox

Memory tip:
Antacids = Acid already there → Neutralize it.

7
New cards

Antibiotics for H. pylori-Associated Peptic Ulcers

Eradicate Helicobacter pylori (H. pylori) to promote ulcer healing and prevent recurrence.

Common antibiotics used:

  • Clarithromycin

  • Amoxicillin

  • Tetracycline

  • Metronidazole

  • Tinidazole

Other medication used:

  • Bismuth compounds (included in bismuth quadruple therapy)

Key point: A minimum of two antibiotics is prescribed, and up to three antibiotics may be used to reduce the risk of antibiotic resistance.

8
New cards

Choosing Antibiotics for H. pylori: Resistance & Current Recommendations

  • Clarithromycin was once the first-choice antibiotic, but it is no longer preferred because clarithromycin resistance is now common.

  • The most common antibiotic combination is:

    • Metronidazole

    • Tetracycline

  • Goal of therapy: Minimize the emergence of antibiotic resistance by using at least two antibiotics, with three antibiotics preferred when appropriate.

9
New cards

Complete Drug Therapy for H. pylori-Associated Ulcers

Treatment for H. pylori ulcers includes more than just antibiotics.

Recommended regimen:

  • At least two antibiotics (preferably three)

  • An antisecretory agent, which should be either:

    • Proton Pump Inhibitor (PPI) or

    • Histamine-2 Receptor Antagonist (H2RA)

Treatment duration:

  • 10-day course: Good eradication rates.

  • 14-day course: Slightly better eradication rates than 10 days.

Overall goal: Completely eradicate H. pylori, heal the ulcer, and reduce the development of antibiotic resistance.

10
New cards

Metronidazole (Flagyl): H. pylori Uses, Mechanism, Adverse Effects, Nursing Considerations, & Patient Teaching

Classification

  • Antiprotozoal antibiotic

Role in H. pylori Treatment

  • First-line choice for H. pylori treatment despite increasing resistance.

  • When combined with bismuth subsalicylate, resistance is overcome (similar concept to combination antibiotics like Zosyn), making it effective as part of bismuth quadruple therapy.

Effectiveness

  • Very effective against sensitive strains of H. pylori.

  • Over 40% of strains are now resistant, which is why combination therapy is recommended.

Common Adverse Effects

  • Nausea

  • Vomiting

  • Diarrhea

  • Headache

Alcohol Interaction (Very Important!)

  • DO NOT drink alcohol while taking metronidazole and for at least 3 days after the last dose.

  • Metronidazole prevents the metabolism of alcohol, causing a disulfiram-like reaction, which may include:

    • Severe nausea and vomiting

    • Throbbing headache

    • Tachycardia

    • Chest pain

  • Check for hidden sources of alcohol, including:

    • Mouthwash

    • Cough syrup

Drug Interactions

  • May increase INR in patients taking warfarin, increasing the risk of bleeding.

Pregnancy

  • Avoid during pregnancy, especially during the first trimester, because it is teratogenic.

Key Nursing & Patient Teaching

  • Teach patients to avoid all alcohol during therapy and for 3 days after the final dose.

  • Instruct patients to read labels for hidden alcohol-containing products.

  • Monitor patients on warfarin for increased INR and signs of bleeding.

  • Explain that metronidazole is commonly used in combination with other medications for successful eradication of H. pylori.

11
New cards

Tetracycline: H. pylori Uses, Adverse Effects, Contraindications, Nursing Considerations, & Patient Teaching

Role in H. pylori Treatment

  • Used as part of bismuth quadruple therapy.

  • Very effective against sensitive strains of H. pylori when combined with metronidazole.

  • Resistance is <1%, making it an excellent choice for H. pylori treatment.

Common Adverse Effects

  • Nausea

  • Vomiting

  • Diarrhea

  • Photosensitivity (increased sensitivity to sunlight)

  • Esophageal ulceration

  • Yellow or brown tooth discoloration, especially in developing teeth

Serious Adverse Effects

  • Superinfection (enterocolitis) – rare but serious

    • Caused by rapid overgrowth of Staphylococcus in the bowel

    • If diarrhea develops, determine the cause before treating because it may indicate superinfection rather than a routine medication side effect.

  • Hepatotoxicity

  • Nephrotoxicity

Contraindications

  • Pregnancy

  • Children (can permanently discolor developing teeth)

Nursing Considerations & Patient Teaching

  • Take with a full glass of water to reduce the risk of esophageal ulceration.

  • Take at bedtime with lots of water (per your notes) to help reduce esophageal irritation/ulceration.

  • Avoid excessive sun exposure and use sunscreen/protective clothing because of photosensitivity.

  • Monitor for severe or persistent diarrhea, which may indicate enterocolitis (superinfection) rather than a common side effect.

  • Do not use during pregnancy or childhood because of the risk of permanent tooth discoloration and effects on developing teeth.

12
New cards

Clarithromycin (Biaxin): Class, Mechanism, H. pylori Uses, Adverse Effects, Nursing Considerations, & Patient Teaching

Classification

  • Macrolide antibiotic

  • Same drug class as:

    • Azithromycin

    • Erythromycin

Mechanism of Action

  • Suppresses the growth of H. pylori by inhibiting protein synthesis.

Role in H. pylori Treatment

  • In the absence of resistance, clarithromycin is highly effective against H. pylori.

  • Resistance is increasing, exceeding 20% in some areas, which is why clarithromycin is no longer the first-choice antibiotic in many treatment guidelines.

Common Adverse Effects

  • Nausea

  • Vomiting

  • Diarrhea

  • Metallic taste (distortion of taste) – a common patient complaint

  • Photosensitivity

Serious Adverse Effects

  • QT interval prolongation

  • Hepatotoxicity

Nursing Considerations

  • Routine ECGs are NOT necessary for routine short courses of clarithromycin, despite the risk of QT prolongation.

  • Monitor for signs of liver toxicity if therapy is prolonged or symptoms develop.

Patient Teaching

  • Teach patients to wear extra sunscreen and protective clothing because photosensitivity is common.

  • Inform patients that a metallic taste is a common side effect and is usually temporary.

  • Advise patients to report symptoms of liver problems (e.g., jaundice, dark urine, severe fatigue) or symptoms of arrhythmias (e.g., palpitations, dizziness, fainting).

13
New cards

Amoxicillin: Class, Mechanism, H. pylori Uses, Adverse Effects, Nursing Considerations, & Patient Teaching

Classification

  • Penicillin (PCN) derivative antibiotic

Mechanism of Action

  • Kills bacteria by disrupting the bacterial cell wall.

Role in H. pylori Treatment

  • H. pylori is highly sensitive to amoxicillin.

  • Resistance is low (about 3%), although reinfection rates are increasing.

  • Poorly effective when used alone, so it is used in combination with other antibiotics and an antisecretory agent as part of H. pylori treatment.

Effect of Gastric pH

  • Antibacterial activity is highest at a neutral pH.

  • Effectiveness is enhanced by reducing stomach acid with an antisecretory agent, such as:

    • Omeprazole (a Proton Pump Inhibitor [PPI])

Adverse Effects

  • Most common side effect: Diarrhea

  • Generally very well tolerated

Nursing Considerations & Patient Teaching

  • Explain that amoxicillin is not effective by itself for H. pylori and should be taken with the other prescribed medications for the full course of therapy.

  • Taking it with a PPI (e.g., omeprazole) helps improve its effectiveness by creating a less acidic (more neutral) environment.

  • Monitor for diarrhea and assess for signs of antibiotic-associated diarrhea if it becomes severe or persistent.

  • Assess for a penicillin allergy before administering because amoxicillin is a penicillin derivative.

14
New cards

Bismuth Compounds (Bismuth Subsalicylate/Pepto-Bismol): Mechanism, Uses, Adverse Effects, Nursing Considerations, & Patient Teaching

Primary Drug

  • Bismuth subsalicylate (Pepto-Bismol)

Mechanism of Action

  • Acts topically to disrupt the cell wall of H. pylori, causing bacterial lysis and death.

  • May inhibit urease activity and prevent H. pylori from adhering to the gastric surface.

  • Coats the stomach, creating a physical protective barrier over raw and irritated tissues to protect them from stomach acid and promote healing.

Role in H. pylori Treatment

  • Used as part of bismuth quadruple therapy for H. pylori eradication.

Adverse Effects

  • Harmless black discoloration of the tongue

  • Harmless black stools

  • Long-term therapy: Possible risk of neurologic injury due to bismuth bioaccumulation, which can lead to encephalopathy.

Nursing Considerations

  • Bismuth can bioaccumulate, increasing the risk of encephalopathy with prolonged use.

  • Outside of specific situations (such as H. pylori treatment), bismuth compounds should not be taken for more than 2 days.

Patient Teaching

  • Explain that black stools and a black tongue are expected, harmless side effects and do not indicate bleeding.

  • Take exactly as prescribed when used for H. pylori treatment.

  • Do not use Pepto-Bismol for longer than 2 days unless specifically directed by the provider (exception: prescribed H. pylori treatment).

  • Report any signs of neurologic changes (confusion, altered mental status, difficulty thinking), especially with prolonged use, as these may indicate bismuth accumulation/encephalopathy.

15
New cards

Proton Pump Inhibitors (PPIs): Mechanism, Uses, Adverse Effects, Nursing Considerations, & Patient Teaching

Mechanism of Action

  • Most effective drugs for suppressing gastric acid secretion.

  • Decrease gastric acid production by inhibiting the proton pump (H⁺/K⁺-ATPase) in the stomach.

Therapeutic Uses (Primarily Short-Term)

  • Gastric ulcers

  • Duodenal ulcers

  • Gastroesophageal reflux disease (GERD)

  • Used as the antisecretory agent in H. pylori treatment regimens

Selection of a PPI

  • PPIs are generally well tolerated.

  • Choice of a specific PPI is usually based on:

    • Cost

    • Prescriber's preference

Adverse Effects & Risks

  • Decreased absorption of minerals and vitamins, including:

    • Calcium

    • Magnesium

    • Vitamin B12

  • Reduced absorption of calcium may increase the risk of fractures.

  • Less stomach acidity allows bacteria to survive more easily in the GI tract, increasing the risk of:

    • Pneumonia

    • Clostridioides difficile (C. diff) intestinal infection

  • Gastric acid rebound can occur after stopping therapy due to increased gastrin production, causing a temporary increase in stomach acid secretion.

Nursing Considerations

  • PPIs are intended primarily for short-term therapy when appropriate.

  • Monitor for signs of:

    • Vitamin B12 deficiency

    • Hypomagnesemia

    • Fractures with long-term use

    • Pneumonia

    • C. difficile infection (persistent or severe diarrhea)

Patient Teaching

  • Take the medication exactly as prescribed.

  • Report persistent diarrhea, which may indicate C. difficile infection.

  • Do not stop PPIs abruptly without provider guidance because acid rebound may occur.

  • If taking PPIs long term, discuss monitoring for calcium, magnesium, and vitamin B12 deficiencies with the healthcare provider.

16
New cards

Omeprazole (Prilosec): Class, Uses, Adverse Effects, Nursing Considerations, & Patient Teaching

Classification

  • Proton Pump Inhibitor (PPI)

  • First available PPI

Mechanism of Action

  • Inhibits gastric acid secretion by blocking the proton pump in the stomach.

Therapeutic Uses

  • FDA-approved for H. pylori treatment (used in combination therapy).

  • Used for short-term therapy of:

    • Gastric ulcers

    • Duodenal ulcers

    • GERD

Characteristics

  • Short half-life

  • Ulcer prophylaxis is indicated only for ICU patients who have an additional risk factor, such as:

    • Multiple trauma

    • Spinal cord injury

    • Prolonged mechanical ventilation (>48 hours)

Adverse Effects

Usually inconsequential with short-term use, but possible adverse effects include:

  • Headache

  • GI effects

  • Pneumonia

  • Fractures

  • Hypomagnesemia

  • Rebound acid hypersecretion

  • Clostridioides difficile (C. difficile) infection

Nursing Considerations

  • Monitor for long-term complications if therapy is prolonged:

    • Low magnesium

    • Fracture risk

    • C. difficile infection

  • Use stress ulcer prophylaxis only when indicated (ICU patients with additional risk factors).

Patient Teaching

  • Take exactly as prescribed.

  • Report persistent diarrhea, which could indicate C. difficile infection.

  • Do not stop the medication abruptly without provider guidance because rebound acid hypersecretion may occur.

  • Report symptoms of hypomagnesemia (muscle cramps, weakness, irregular heartbeat) if taking long term.

17
New cards

Nondrug Therapy for Peptic Ulcer Disease (PUD): Diet & Lifestyle Modifications

Diet

  • The traditional "ulcer diet" (bland, soft, low-fiber diet) was previously recommended to reduce acid production but is not evidence-based and does not accelerate ulcer healing.

  • There is no convincing evidence that caffeinated beverages cause ulcers or delay healing.

  • Eating 5–6 small meals per day helps reduce gastric pH fluctuations, which may improve symptom control.

Avoid

These substances irritate the gastric mucosa and delay ulcer healing:

  • Smoking (tobacco)

  • Alcohol

  • Aspirin (ASA)

  • Nonsteroidal anti-inflammatory drugs (NSAIDs)

Stress

  • Stress is directly associated with increased gastric acid production.

  • Stress reduction is an important nonpharmacologic intervention for patients with peptic ulcer disease.

Key Nursing & Patient Teaching

  • Encourage patients to eat smaller, more frequent meals rather than relying on a restrictive "ulcer diet."

  • Teach patients to avoid smoking, alcohol, aspirin, and NSAIDs because they slow ulcer healing and increase mucosal irritation.

  • Encourage stress-management techniques (e.g., relaxation, exercise as appropriate, adequate sleep) to help reduce acid production and improve symptoms.

18
New cards

NSAID-Induced Ulcers: Prophylaxis, Treatment, Evaluation, Nursing Considerations, & Patient Teaching

Overview

  • NSAID-induced ulcers are more of a straightforward gastrointestinal bleed (GIB).

  • They have a lower risk of recurrence than H. pylori-associated ulcers once the NSAID is discontinued.

Risk Factors for Ulcer Development

  • Age >60 years

  • History of peptic ulcers

  • High-dose NSAID therapy

Prophylaxis (Prevention)

  • Proton Pump Inhibitors (PPIs) (e.g., omeprazole) are the preferred drugs for ulcer prevention in high-risk patients taking NSAIDs.

  • Misoprostol is also effective but commonly causes diarrhea.

Treatment

  • First step: Remove the cause by discontinuing NSAIDs whenever possible.

  • Histamine-2 receptor antagonists (H2 blockers) and PPIs are the preferred medications for treatment.

  • During an acute GI bleed, blood thinners (including aspirin [ASA]) are often stopped temporarily, if clinically appropriate.

Evaluation of Treatment

Treatment is considered successful when there is:

  • Resolution of symptoms

  • Stabilization of laboratory values (indicating the bleeding has stopped and healing is occurring)

Patient Teaching

  • Do not combine aspirin (ASA) with other NSAIDs, as this significantly increases the risk of ulcer formation and GI bleeding.

  • If long-term pain control is needed, discuss alternative therapies with the healthcare provider.

  • Take ulcer-prevention medications exactly as prescribed if continued NSAID therapy is necessary.

19
New cards

Histamine-2 Receptor Antagonists (H2RAs): Drugs, Mechanism, Uses, Adverse Effects, Nursing Considerations, & Patient Teaching

Drugs

  • Cimetidine (Tagamet)

  • Ranitidine (Zantac)withdrawn from the market

  • Famotidine (Pepcid)

  • Nizatidine (Axid)

Mechanism of Action

  • Histamine stimulates H2 receptors in the stomach, increasing gastric acid secretion.

  • H2 receptor antagonists selectively block H2 receptors in the stomach (rather than H1 receptors throughout the body like traditional antihistamines).

  • Suppress gastric acid secretion, especially:

    • Basal acid production

    • Nocturnal (nighttime) acid production

  • They do NOT completely stop acid secretion, because the stomach can still produce increased acid in response to food.

Therapeutic Uses

  • First-choice drugs for treating gastric and duodenal ulcers

  • Promote ulcer healing by suppressing gastric acid secretion.

  • GERD treatment

Adverse Effects

  • Serious adverse effects are uncommon.

Nursing Considerations

  • Most effective for reducing basal and nighttime acid secretion.

  • Less effective at suppressing meal-stimulated acid secretion than Proton Pump Inhibitors (PPIs).

Patient Teaching

  • Take as prescribed to promote ulcer healing and control GERD symptoms.

  • Understand that these medications reduce stomach acid but do not completely eliminate acid production, especially after meals.

  • Ranitidine (Zantac) is no longer available because it has been withdrawn from the market.

20
New cards

Cimetidine (Tagamet): Mechanism, Pharmacokinetics, Therapeutic Uses, Adverse Effects, Drug Interactions, Nursing Considerations, & Patient Teaching

Classification

  • Histamine-2 Receptor Antagonist (H2RA)

Mechanism of Action

  • Blocks H2 receptors in the stomach, reducing gastric acid secretion.

Pharmacokinetics

  • Absorption is slowed if taken with meals.

  • Crosses the blood-brain barrier with difficulty, but can still produce CNS side effects.

Therapeutic Uses

  • Gastric ulcers

  • Duodenal ulcers

  • Gastroesophageal reflux disease (GERD)

  • Zollinger-Ellison syndrome

  • Relief of:

    • Heartburn

    • Acid indigestion

    • Sour stomach

Adverse Effects

  • Antiandrogenic effects

  • CNS effects:

    • Confusion

    • Agitation

    • Drowsiness

  • Pneumonia, due to reduced stomach acid allowing bacterial overgrowth (loss of the stomach's protective bacterial barrier)

Drug Interactions

  • Can interact with:

    • Warfarin

    • Phenytoin

    • Theophylline

    • Lidocaine

  • Antacids decrease the absorption of cimetidine.

    • Administer cimetidine and antacids at least 1 hour apart.

Current Role in Therapy

  • No longer considered first-line therapy.

  • Proton Pump Inhibitors (PPIs) generally provide equal or better ulcer healing with fewer adverse effects.

Nursing Considerations

  • Monitor for confusion or drowsiness, especially in older adults.

  • Assess for potential drug interactions, particularly in patients taking warfarin, phenytoin, theophylline, or lidocaine.

  • Separate administration from antacids by at least 1 hour.

Patient Teaching

  • Take antacids at least 1 hour before or after cimetidine.

  • Report confusion, excessive drowsiness, or other CNS changes.

  • Inform the healthcare provider of all medications being taken because cimetidine has multiple drug interactions.

  • Explain that PPIs are now generally preferred because they have fewer side effects and similar or greater effectiveness.

21
New cards

Misoprostol (Cytotec): Class, Mechanism, Therapeutic Uses, Adverse Effects, Contraindications, Nursing Considerations, & Patient Teaching

Classification

  • Synthetic prostaglandin (Prostaglandin analog)

  • "Rest and digest" drug

Mechanism of Action

Misoprostol enhances the stomach's natural defenses by:

  • Helping rebuild the stomach lining (gastric mucosa)

  • Increasing blood flow to the gastric mucosa

  • Stimulating bicarbonate production, which helps neutralize stomach acid

  • Reducing gastric acid secretion while enhancing mucosal protection

Therapeutic Uses

  • Only FDA-approved GI indication: Prevention of gastric ulcers caused by long-term NSAID therapy

Most Common Adverse Effects

  • Dose-related diarrhea

  • Abdominal pain

  • Abdominal cramping

  • Nausea

  • Vomiting

Serious Adverse Effects

  • Can cause cervical cramping

  • Can stimulate uterine contractions (rare but clinically significant)

Contraindications

  • Pregnancy

    • Misoprostol can stimulate uterine contractions and may cause miscarriage.

    • Significant precautions must be taken to ensure the patient is NOT pregnant before starting therapy and does not become pregnant while taking the medication.

Nursing Considerations

  • Assess pregnancy status before initiating therapy.

  • Monitor for dose-related GI effects (especially diarrhea and abdominal cramping).

  • Used primarily for NSAID-induced ulcer prevention, not routine ulcer treatment.

Patient Teaching

  • Do not use during pregnancy.

  • Use effective contraception if pregnancy is possible while taking misoprostol.

  • Report severe abdominal cramping or persistent diarrhea.

  • Explain that diarrhea and abdominal pain are the most common side effects and are often dose related.

22
New cards

Sucralfate (Carafate): Class, Mechanism, Therapeutic Uses, Adverse Effects, Drug Interactions, Nursing Considerations, & Patient Teaching

Classification

  • Mucosal protectant

Mechanism of Action

  • Forms a thick, sticky protective coating over ulcers and the stomach lining.

  • Creates a protective barrier that lasts up to 6 hours, shielding the ulcer from acid, pepsin, and bile to promote healing.

  • Requires an acidic environment to work.

  • Minimal systemic absorption, so most of its effects are local within the GI tract.

Therapeutic Uses

  • Acute gastric and duodenal ulcers

  • Maintenance therapy to prevent ulcer recurrence

Adverse Effects

  • Most common: Constipation (caused by the viscosity/thickness of Carafate)

  • Constipation occurs in about 2% of patients (per your lecture slide)

  • May also cause:

    • Dry mouth

    • Nausea

Drug Interactions

  • Minimal systemic drug interactions

  • Antacids interfere with the action of sucralfate because an acidic environment is required for the medication to work.

  • Separate antacids and sucralfate by at least 30 minutes.

Special Considerations

  • Use caution in patients with renal impairment, as the aluminum contained in sucralfate may bioaccumulate.

Nursing Considerations

  • Administer on an empty stomach, at least 1 hour before meals.

  • Give at least 30 minutes apart from antacids.

  • Monitor for constipation and encourage fluids/fiber if appropriate.

  • Monitor patients with renal impairment for signs of aluminum accumulation if used long term.

Patient Teaching

  • Take on an empty stomach at least 1 hour before meals.

  • Do not take with antacids—separate doses by at least 30 minutes.

  • Explain that sucralfate does not reduce stomach acid; instead, it forms a protective barrier over ulcers to allow healing.

  • Increase fluids (if not contraindicated) and report persistent constipation.

  • Patients with kidney disease should inform their provider before taking sucralfate because of the risk of aluminum accumulation.

23
New cards

Antacids: Mechanism, Uses, Adverse Effects, Drug Interactions, Nursing Considerations, & Patient Teaching

Classification

  • Weak bases that neutralize existing stomach acid.

  • Most antacids are metal-based (e.g., aluminum, magnesium, calcium compounds).

Mechanism of Action

  • React with gastric acid to produce neutral salts or salts with low acidity, thereby:

    • Neutralizing stomach acid

    • Reducing destruction of the gastric mucosa (gut wall)

    • May also enhance mucosal protection by stimulating prostaglandin production

Effects on pH

  • Except for sodium bicarbonate, antacids do not significantly alter systemic pH.

Therapeutic Uses

  • Rapid relief of symptoms caused by excess stomach acid (e.g., heartburn, acid indigestion, sour stomach).

Adverse Effects

  • Aluminum hydroxide → Constipation

  • Magnesium hydroxide → Diarrhea

  • Sodium-containing antacids → Sodium loading

Renal Considerations

  • Use with caution in patients with renal impairment.

  • Because antacids are metal-based, aluminum and magnesium can bioaccumulate in kidney disease.

Drug Interactions

Antacids decrease the effectiveness of medications that require an acidic environment, including:

  • Cimetidine (Tagamet)

  • Sucralfate (Carafate)

Nursing Considerations

  • Assess kidney function before recommending frequent or long-term antacid use.

  • Monitor for constipation or diarrhea depending on the type of antacid used.

  • Be aware of sodium content in patients with conditions requiring sodium restriction.

Patient Teaching

  • Antacids provide quick symptom relief by neutralizing acid already present; they do not reduce acid production.

  • If you have kidney disease, consult your healthcare provider before using antacids because metal components can accumulate.

  • Separate antacids from cimetidine and sucralfate because those medications require an acidic environment to work properly.

  • Choose the type of antacid based on side effects:

    • Aluminum = Constipation

    • Magnesium = Diarrhea